2021 Fiscal Year Final Research Report
Development of Breast Cancer Surgery Support System for MRI non mass enhancement Using Virtual Reality Technology
Project/Area Number |
19K09059
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Review Section |
Basic Section 55010:General surgery and pediatric surgery-related
|
Research Institution | Aichi Medical University |
Principal Investigator |
Nakano Shogo 愛知医科大学, 医学部, 教授 (20351108)
|
Co-Investigator(Kenkyū-buntansha) |
藤井 公人 愛知医科大学, 医学部, 准教授 (00524331)
高阪 絢子 愛知医科大学, 医学部, 助教 (50440748)
塩見 有佳子 (毛利有佳子) 愛知医科大学, 医学部, 講師 (90465576)
安藤 孝人 愛知医科大学, 医学部, 助教 (40634134)
井戸 美来 愛知医科大学, 医学部, 助教 (70740968)
伊藤 由季絵 愛知医科大学, 医学部, 助教 (10805469)
|
Project Period (FY) |
2019-04-01 – 2022-03-31
|
Keywords | Breast cancer / MRI / Non mass enhancement / RVS / 乳房温存手術 |
Outline of Final Research Achievements |
We evaluated the usefulness of second-look US combined with ultrasound fusion technology (real-time virtual sonography: RVS) in defining the extent of breast cancer in breast-conserving surgery for breast cancer with Non-mass enhancement (NME). 6 cases were included in the study. After additional supine MRI, second-look US was performed using RVS. After tracing the contrast-enhanced area on the skin with RVS, implantable lesion identification markers were placed and surgery was performed. MRI showed a median diameter of 30.0 mm (23-36), with a distribution of 4 NME and 2 NME+mass. US showed a median diameter of 14.5mm (11-32), with a distribution of 2 NME and 4 NME+mass. All patients underwent breast-conserving surgery. The final pathological diagnosis was DCIS in 4 cases and IDC in 2. All were negative for resection margins, and there were no cases of reoperation. RVS may contribute to improved surgical outcomes in breast-conserving surgery for breast cancer with NME.
|
Free Research Field |
乳癌画像診断
|
Academic Significance and Societal Importance of the Research Achievements |
RVSはMRI-NMEの多くを検出できる革新的な画像診断法であり、世界に発信しうる独創的な新技術であることをfeasibility試験で検証できた。今後症例を増やしNMEの広がり診断においてRVSを用いて乳房温存手術のsurgical outcomeが改善されることが証明できれば、RVSによって必要のない乳房全摘術を回避することが可能となる。またMRIガイド下生検が必要な症例をより厳選することが可能となり、医師、患者の負担を軽減することができる。
|